PharmaShots | Incisive News in 3 Shots

Subscribe Now

Nurix

Nurix Reports Positive Results of BTK degraders, NX-5948 and NX-2127 in P-Ia/Ib Trial for the Treatment of Lymphoma

Nurix Reports Positive Results of BTK degraders, NX-5948 and NX-2127 in P-Ia/Ib Trial for the Treatment of Lymphoma

December 12, 2023

Nurix Entered into a Multi-Year, Multi-Target Strategic Collaboration Agreement with Seagen to Advance an Innovative New Class of Cancer Therapies

Nurix Entered into a Multi-Year, Multi-Target Strategic Collaboration Agreement with Seagen to Advance an Innovative New Class of...

September 8, 2023

Top 20 Life Sciences Deals of 2020 by Total Deal Value

Top 20 Life Sciences Deals of 2020 by Total Deal Value

January 22, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us